DavidStephenPardaMD

Radiation Oncology • Pittsburgh, PA

Associate Professor of Radiation Oncology, Drexel University College of Medicine

Join to view full profile

Dr. Parda is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Parda's full profile

Already have an account?

Office
320 E North Ave
Pittsburgh, PA 15212
Phone+1 412-359-3400

Fax+1 412-359-3171

Education & Training

MedStar Health/Georgetown University HospitalResidency, Radiation Oncology, 1991 - 1995
Cleveland Clinic FoundationResidency, Internal Medicine, 1988 - 1991
University of South Florida College of MedicineClass of 1988

Certifications & Licensure

PA State Medical License 1998 - 2024
MD State Medical License 1995 - 1999
DC State Medical License 1992 - 1998
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

Pittsburgh Magazine Castle Connolly, 2011

Clinical Trials

Radiation Therapy in Treating Women Who Have Undergone Surgery for Early-Stage Invasive Breast Cancer Start of enrollment: 2000 Mar 09
Completed
Not Applicable
Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer Start of enrollment: 2005 Mar 01
Completed
Not Applicable
Radiation Therapy Outreach Program for Minority or Low-Income Patients With Newly Diagnosed Cancer Start of enrollment: 2004 Oct 01
Completed
Not Applicable
Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer Start of enrollment: 2008 Feb 01
Active, not recruiting
Phase 3
Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2009 Apr 15
Completed
Phase 3
The Impact of Retropubic Lidocaine vs Saline on Postoperative Urinary Retention Following Midurethral Sling Start of enrollment: 2019 Nov 25
Recruiting
Phase 4
Join now to see all

Publications & Presentations

PubMed

Quality-of-Life Outcomes from NRG/NSABP B-39/RTOG 0413: Whole-breast Irradiation vs Accelerated Partial-breast Irradiation after Breast Conserving Surgery.
Patricia A Ganz, Reena S Cecchini, Julia R White, Frank A Vicini, Douglas W Arthur
Journal of the National Cancer Institute. 2024-09-10
23 citations
Comparison of Radiation With or Without Concurrent Trastuzumab for HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy: A Phase III Clinical Trial.
Melody A. Cobleigh, Stewart J. Anderson, Kalliopi P. Siziopikou, Douglas W. Arthur, Rachel Rabinovitch
Journal of Clinical Oncology. 2021-03-19
266 citations
Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence t...
Frank A. Vicini, Reena S. Cecchini, Julia White, Douglas W. Arthur, Thomas B. Julian
Lancet. 2019-12-14

Press Mentions

Allegheny General Hospital to Get New PresidentJanuary 31st, 2022
$78 Million Center at Allegheny General Hospital Caps W. Pa. Cancer Treatment ExpansionJuly 27th, 2020
Highmark Health, Allegheny Health Network Unveil New Flagship Cancer Center at AGHJuly 27th, 2020
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member